The company reported two-year biomarker results from an open-label trial arm testing Rezdiffra in patients with compensated MASH cirrhosis. More: Madrigal touts biomarker data in key MASH population as it works to grow Rezdiffra's reach Source: fierce
read moreRoche has earmarked more than $700 million to construct a sprawling new plant for its Genentech unit in Holly Springs, North Carolina. The new plant, which will be used for fill and finish of next-generation obesity drugs, forms part of
read more
Private equity firm Apiary Capital backs rapid growth of performance-i More: Apiary invests in life sciences marketing specialist performance-io Source: News
read moreVerastem Oncology has gained its first FDA approval, winning an accelerated nod for the combination treatment of avutometinib and defactinib for a rare form of ovarian cancer. With the commercial name of Avmapki Fakzynja Co-Pack, the combo becomes the first
read moreRoche is investing roughly $282 million to erect a new biomanufacturing hub in Shanghai. The plant, which will mark Roche’s second for branded medicines in the country, will mainly be used for domestic production of the eye med Vabysmo., More:
read moreThe addition of Imfinzi to standard-of-care Bacillus Calmette-Guérin (BCG) induction and maintenance therapy helped patients live longer without their disease coming back, AstraZeneca said on Friday. More: AstraZeneca opens the door to Imfinzi expansion with trial win in high-risk bladder
read more© 1994 - 2026 B.M. Pharmaceuticals